Charles River Laboratories
Statements
Segments
US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Charles River Laboratories (CRL). It shows which part of the business is growing — and which one is holding it back.
Revenue by business segment
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| DSA | – | – | – | $2.62B 63.3% | $2.45B 60.5% · -6.3% | $2.40B 59.8% · -2.0% |
| RMS | – | – | – | $792.3M 19.2% | $829.4M 20.5% · +4.7% | $846.1M 21.1% · +2.0% |
| Manufacturing | – | – | – | $721.4M 17.5% | $769.3M 19.0% · +6.6% | $766.4M 19.1% · -0.4% |
| RMS | $571.2M 19.5% | $690.4M 19.5% · +20.9% | $739.2M 18.6% · +7.1% | – | – | – |
| DSA | $1.84B 62.8% | $2.11B 59.5% · +14.7% | $2.45B 61.6% · +16.1% | – | – | – |
| Manufacturing | $515.4M 17.6% | $742.5M 21.0% · +44.1% | $789.6M 19.9% · +6.3% | – | – | – |
| Segment operating income | – | – | – | – | – | – |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| DSA | – | – | – | – | – | – |
| RMS | – | – | – | – | – | – |
| Manufacturing | – | – | – | – | – | – |
| RMS | – | – | – | – | – | – |
| DSA | – | – | – | – | – | – |
| Manufacturing | – | – | – | – | – | – |
| Segment operating income | – | – | – | $849.1M | $485.5M | $284.8M |
Large figure: segment operating income. Below it the margin, that is operating income measured against the revenue of the same segment.
Revenue by region
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| U.S. | $1.63B 55.6% | $1.93B 54.6% · +18.9% | $2.34B 58.9% · +21.1% | $2.35B 56.8% · +0.2% | $2.24B 55.3% · -4.6% | $2.14B 53.3% · -4.4% |
| Europe | $829.3M 28.4% | $1.04B 29.3% · +25.0% | $1.03B 26.0% · -0.4% | $1.08B 26.1% · +4.3% | $1.08B 26.6% · +0.1% | $1.10B 27.5% · +2.3% |
| Canada | $306.3M 10.5% | $339.1M 9.6% · +10.7% | $399.0M 10.0% · +17.7% | $487.3M 11.8% · +22.1% | $482.1M 11.9% · -1.1% | $501.0M 12.5% · +3.9% |
| Asia Pacific | $155.1M 5.3% | $222.9M 6.3% · +43.7% | $192.8M 4.8% · -13.5% | $200.8M 4.9% · +4.1% | $197.0M 4.9% · -1.9% | $205.0M 5.1% · +4.1% |
| Other | $6.1M 0.2% | $7.3M 0.2% · +19.0% | $10.0M 0.3% · +36.6% | $16.8M 0.4% · +69.2% | $52.8M 1.3% · +213.5% | $64.9M 1.6% · +22.8% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Revenue by product line
| Segment | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Service | $2.30B 78.5% | $2.76B 77.8% · +20.0% | $3.22B 80.9% · +16.7% | $3.44B 83.3% · +6.9% | $3.30B 81.6% · -4.0% | $3.25B 80.9% · -1.6% |
| Product | $627.8M 21.5% | $784.6M 22.2% · +25.0% | $759.2M 19.1% · -3.2% | $689.4M 16.7% · -9.2% | $745.9M 18.4% · +8.2% | $765.3M 19.1% · +2.6% |
Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.
Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.